Back to User profile » Dr Peter Bramlage
Papers published by Dr Peter Bramlage:
Risk Factor Management in Non-Metropolitan Patients with Coronary and Peripheral Artery Disease – A Protocol of a Prospective, Multi-Center, Quality Improvement Strategy
Zemmrich C, Bramlage P, Hillmeister P, Sacirovic M, Buschmann I
Vascular Health and Risk Management 2021, 17:267-272
Published Date: 27 May 2021
A Difference Between Bedtime and Pre-Breakfast Plasma Glucose Levels Indicates the Need for Prandial Insulin in Basal Insulin-Treated Type 2 Diabetic Patients with Normal Fasting Glucose
Kress S, Borck A, Zisman A, Bramlage P, Siegmund T
Diabetes, Metabolic Syndrome and Obesity 2021, 14:1215-1222
Published Date: 18 March 2021
Real-World Effectiveness of Insulin Glargine 300 Initiation in Switzerland
Thomann R, Zechmann S, Alexander-David N, Jornayvaz FR
Diabetes, Metabolic Syndrome and Obesity 2020, 13:2359-2365
Published Date: 3 July 2020
Factors influencing dyslipidemia in statin-treated patients in Lebanon and Jordan: results of the Dyslipidemia International Study
Azar ST, Hantash HA, Jambart S, El-Zaheri MM, Rachoin R, Chalfoun A, Lahoud L, Okkeh O, Bramlage P, Brudi P, Ambegaonkar BM
Vascular Health and Risk Management 2014, 10:225-235
Published Date: 7 May 2014
Efficacy and safety of insulin glargine added to a fixed-dose combination of metformin and a dipeptidyl peptidase-4 inhibitor: results of the GOLD observational study
Seufert J, Pegelow K, Bramlage P
Vascular Health and Risk Management 2013, 9:711-717
Published Date: 13 November 2013